SCHEMBL4035356

SCHEMBL4035356

O=C(NCc1ccc(C(F)(F)F)cc1)C1CCNCC1

nearest known ligand 0.64

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.64
SMN1; SMN2 Q16637 1/20 0.64
HTR2C P28335 1/20 0.60
KCNH2 Q12809 3/20 0.54
EPHX2 P34913 1/20 0.54
MC4R P32245 1/20 0.53
F10 P00742 1/20 0.53
P2RX7 Q99572 3/20 0.52
OGA O60502 1/20 0.49
HDAC6 Q9UBN7 1/20 0.49
USP2 O75604 1/20 0.49
HPGD P15428 1/20 0.49
ERCC1 P07992 1/20 0.48
ERCC4 Q92889 1/20 0.48
MAPT P10636 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15844342 0.87 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2HTR2CEPHX2
SCHEMBL26154086 0.87 ALDH1A1 (0.65) ALDH1A1KCNH2MC4RP2RX7OGA
SCHEMBL5534711 0.86 HDAC6 (0.66) ALDH1A1KCNH2P2RX7HDAC6USP2
SCHEMBL31414598 0.85 KMT2A (0.62) ALDH1A1SMN1; SMN2HTR2CEPHX2P2RX7
SCHEMBL4036835 0.85 KMT2A (0.62) ALDH1A1SMN1; SMN2HTR2CEPHX2P2RX7
SCHEMBL6861732 0.84 HTR2C (0.62) ALDH1A1SMN1; SMN2HTR2CKCNH2MC4R
SCHEMBL21541003 0.84 HTR2C (0.62) ALDH1A1SMN1; SMN2HTR2CKCNH2MC4R
SCHEMBL4037264 0.84 ALDH1A1 (0.68) ALDH1A1SMN1; SMN2HTR2CUSP2HPGD
Hydrochloric Acid SCHEMBL6479155 0.83 ALDH1A1 (0.67) ALDH1A1SMN1; SMN2HTR2CUSP2HPGD
SCHEMBL20811294 0.82 HTR2C (0.62) HTR2CKCNH2MC4RP2RX7HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1501467-A4 HETEROCYCLO INHIBITORS OF POTASSIUM CHANNEL FUNCTION BRISTOL MYERS SQUIBB CO (US) 2009-08-19 EP disclosed
EP-1501467-A2 HETEROCYCLO INHIBITORS OF POTASSIUM CHANNEL FUNCTION Bristol-Myers Squibb Company (US) 2005-02-02 EP disclosed
WO-2003088908-A2 HETEROCYCLO INHIBITORS OF POTASSIUM CHANNEL FUNCTION BRISTOL-MYERS SQUIBB COMPANY (US) 2003-10-30 WO disclosed